+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cholera Vaccines Market by Vaccine Type, Route of Administration, Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast to 2030- Product Image
Cholera Vaccines Market by Vaccine Type, Route of Administration, Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast to 2030- Product Image
Sale

Cholera Vaccines Market by Vaccine Type, Route of Administration, Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968086
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cholera Vaccines Market grew from USD 307.02 million in 2024 to USD 329.81 million in 2025. It is expected to continue growing at a CAGR of 7.36%, reaching USD 470.18 million by 2030.

Setting the Stage for Cholera Vaccine Market Evolution

The global cholera vaccine market stands at a pivotal juncture, driven by evolving epidemiological patterns, heightened public health priorities, and intensified research efforts. In recent years, outbreaks in regions with fragile health systems have underscored the critical need for robust prevention strategies. Concurrently, advancements in vaccine formulation and distribution infrastructure have created fertile ground for expanding immunization coverage.

This executive summary distills the essential market dynamics shaping the cholera vaccine landscape. It synthesizes the transformative shifts in research and development, examines regulatory influences and trade policies, and highlights the implications of United States tariffs imposed in 2025. By weaving together granular segmentation insights and regional variations, we provide a holistic view of market drivers, challenges, and opportunities that demand strategic attention.

Designed for decision-makers, healthcare professionals, and investors, this overview balances rigorous analysis with accessible narrative. It lays the foundation for informed strategy development and highlights actionable steps to capitalize on emerging trends. As the public health community seeks to mitigate the burden of cholera, understanding these market forces will be essential for guiding future investments and policy interventions.

Pivotal Changes Reshaping Cholera Vaccine Development

Over the past decade, the cholera vaccine market has undergone a profound transformation propelled by scientific breakthroughs and shifting stakeholder priorities. Novel oral formulations leveraging live-attenuated strains have enhanced immunogenicity while simplifying deployment in resource-limited settings. Simultaneously, adjuvant innovations in injectable platforms have improved durability of protection and broadened the appeal among national immunization programs.

Regulatory frameworks have adapted to these advances, with accelerated pathways and emergency use listings enabling faster market entry for high-potential candidates. Partnerships between biopharmaceutical companies and global health agencies have expanded access through tiered pricing schemes, ensuring that lower-income countries can secure sufficient supply without compromising affordability.

In parallel, digital health technologies have emerged as catalysts for efficiency. Cold chain monitoring solutions and data-driven distribution platforms have streamlined vaccine delivery, reducing wastage and optimizing stock management. Collectively, these shifts have not only increased the resilience of immunization campaigns but have also redefined the competitive landscape, compelling established players and new entrants to align their strategies with the evolving needs of public health systems.

Assessing the Ripple Effects of 2025 United States Tariffs

The introduction of new tariff measures by the United States in 2025 has reverberated across the global cholera vaccine supply chain. These duties, applied to select vaccine components and bioprocessing equipment, have elevated production costs for manufacturers relying on U.S.-sourced raw materials. As a result, some producers have pivoted to regional suppliers in Asia and Europe, fostering the growth of alternative supply hubs.

Beyond raw materials, tariffs have also affected the cost dynamics of exporting finished vaccine doses to North America. Importers have faced higher landed costs, prompting negotiations on pricing and cost-sharing mechanisms with international manufacturers. In response, a few firms have relocated portions of their fill-finish operations to countries outside the United States, leveraging favorable trade agreements and cost-efficient manufacturing ecosystems.

These adjustments have prompted a re-evaluation of global procurement strategies, with national immunization initiatives exploring cooperative purchasing and pooled procurement to mitigate tariff-induced price volatility. While the short-term impact has been an uptick in unit costs for certain segments, the recalibration of supply chain networks has the potential to strengthen long-term resilience by diversifying sourcing and manufacturing footprints.

Unveiling Core Market Segments Driving Growth

Understanding the heterogeneity of demand and procurement behavior requires a nuanced segmentation lens. When viewed through the prism of vaccine type, the market bifurcates into injectable products valued for their extended shelf life and strong immunogenic profiles, while oral vaccines gain traction for their ease of administration during mass campaigns in low-resource environments. The route of administration further nuances these distinctions as intramuscular formulations remain a mainstay in clinical settings whereas oral delivery dominates emergency response efforts.

Dosage form introduces another layer of differentiation between liquid preparations that offer immediate deployment and lyophilized variants that enhance stability in challenging climates. Presentation type adds strategic considerations, with multi-dose vials enabling cost efficiencies for large-scale programs and single-dose containers preferred where cold chain reliability is paramount.

Distribution channel segmentation underscores the interplay between institutional and consumer markets as hospital pharmacies and ambulatory care centers drive steady demand, while online pharmacy platforms and retail outlets broaden patient access in urban areas. In parallel, the end user segment delineates the priorities of ambulatory centers and research facilities conducting vaccine trials versus hospitals and clinics managing routine immunization. Age group segmentation reveals a triad of target populations-pediatric cohorts benefiting from prophylactic campaigns, adult groups requiring booster coverage, and geriatric individuals with heightened vulnerability. Finally, application divides demand into prophylactic immunization to prevent outbreaks and therapeutic interventions aimed at containing localized transmissions.

Regional Dynamics Shaping Cholera Vaccine Uptake

Regional dynamics are pivotal in shaping both demand and supply strategies. In the Americas, concerted investments in public health infrastructure and cross-border collaboration have fortified surveillance networks and expedited rollout of oral vaccines during outbreak spikes. Governments in Latin America have entered advanced procurement agreements, securing doses at preferential prices and establishing regional fill-finish capacities to reduce lead times.

Within Europe, Middle East & Africa, diverse epidemiological profiles drive tailored market responses. European Union members maintain strategic stockpiles and engage in joint procurement mechanisms to ensure rapid deployment. Middle Eastern nations leverage robust healthcare funding for domestic vaccine initiatives, while sub-Saharan countries partner with global alliances to expand coverage in high-incidence zones. Such cooperative frameworks have amplified access while encouraging local manufacturing ventures.

Across the Asia-Pacific, thriving biotechnology sectors in China, India, and Southeast Asia are spearheading innovation in vaccine technology. These markets have attracted licensing agreements and technology transfers, bolstering regional self-sufficiency. Concurrently, governments have instituted mass immunization drives supported by streamlined regulatory approvals, underscoring the region’s crucial role in global supply resilience.

Competitive Landscape and Leading Innovators

The competitive terrain features a blend of established pharmaceutical giants and nimble biotechnology enterprises. Leading innovators have differentiated through sustained investment in research collaborations with academic institutions and global health organizations. Several key players have prioritized platform technologies enabling rapid adaptation of vaccine strains in response to emerging cholera variants.

Collaborative consortia and joint ventures have emerged as effective vehicles for pooling resources and expediting late-stage clinical trials. Meanwhile, select firms have adopted modular manufacturing approaches to optimize capacity utilization and minimize downtime between production runs. Strategic alliances with contract development and manufacturing organizations have further allowed companies to scale operations without incurring significant capital expenditures.

Intellectual property strategies have also shaped market positioning. Cross-licensing agreements and patent pooling arrangements have facilitated broader technology dissemination, while safeguarding core innovations that confer competitive advantages. As market entry barriers evolve, mid-sized developers are exploring niche opportunities, such as combination vaccines targeting cholera and other enteric pathogens, signaling the next frontier in product diversification.

Strategic Imperatives for Industry Leadership

To capitalize on the momentum within the cholera vaccine domain, industry leaders should pursue integrated strategies that align R&D, manufacturing, and market access initiatives. Establishing regional production hubs through strategic partnerships or brownfield expansions will mitigate cross-border trade risks and enhance supply agility. Additionally, diversifying raw material sourcing to include emerging suppliers can reduce exposure to tariff fluctuations and strengthen cost predictability.

Embracing digital transformation will be critical. Deploying end-to-end supply chain visibility platforms will facilitate real-time inventory management and expedite distribution during crisis responses. On the demand side, leveraging predictive analytics to forecast outbreak patterns can optimize stock allocation and minimize wastage. Engaging with public health stakeholders and multilateral agencies early in the product lifecycle will ensure alignment with immunization schedules and secure advance purchase commitments.

Finally, cultivating a value-based dialogue with payers and policymakers around the broader economic and social benefits of cholera vaccination can unlock sustainable funding streams. Articulating the cost savings associated with averted treatment and productivity losses will position vaccines as indispensable investments in global health security.

Rigorous Framework Underpinning Research Integrity

This analysis is grounded in a comprehensive review of primary data sources including regulatory filings, company disclosures, and interviews with key opinion leaders across clinical, manufacturing, and policy domains. Secondary research encompassed peer-reviewed literature, industry reports, and databases tracking global immunization trends.

Quantitative insights were validated through triangulation of shipment statistics, procurement tenders, and trade data. Qualitative perspectives were synthesized from discussions with epidemiologists, supply chain experts, and public health officials. Geospatial analysis of cholera incidence informed regional demand assumptions, while patent landscape assessments provided context for competitive positioning.

A collaborative peer review process ensured methodological rigor, with findings cross-checked against independent market monitors and subject matter experts. This robust research framework guarantees the reliability of the insights and recommendations presented herein.

Synthesis of Key Findings and Future Outlook

The convergence of scientific innovation, policy adaptation, and strategic partnerships has charted a promising trajectory for cholera vaccine development and deployment. Despite geopolitical and trade headwinds, emerging manufacturing ecosystems and digital enablers have fortified the market’s capacity to meet fluctuating demand. Segmentation analyses reveal distinct pathways to value creation across product types, distribution channels, and end-user groups.

Region-specific insights underscore the necessity of tailored approaches, from joint procurement mechanisms in Europe to technology transfer initiatives in Asia-Pacific. Meanwhile, leading companies demonstrate that collaborative R&D models and modular manufacturing can accelerate timeline-to-market while preserving quality standards. The actionable recommendations outlined here provide a blueprint for stakeholders seeking to seize opportunities and address persistent gaps in global cholera prevention.

As the public health community advances toward universal immunization coverage, the strategic choices made today will determine the market’s resilience and impact. By aligning investments with data-driven insights and fostering partnerships across sectors, the industry can achieve sustainable progress in mitigating the burden of cholera worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Vaccine Type
    • Injectable Vaccine
    • Oral Vaccine
  • Route Of Administration
    • Intramuscular
    • Oral
  • Dosage Form
    • Liquid
    • Lyophilized
  • Presentation Type
    • Multi Dose
    • Single Dose
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Ambulatory Centers
    • Clinics
    • Hospitals
    • Research Facilities
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
  • Application
    • Prophylactic
    • Therapeutic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • EuBiologics Co., Ltd.
  • Shantha Biotechnics Private Limited
  • Incepta Vaccine Ltd.
  • Sanofi Pasteur S.A.
  • Valneva SE
  • Emergent BioSolutions Inc.
  • Bharat Biotech International Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cholera Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Injectable Vaccine
8.3. Oral Vaccine
9. Cholera Vaccines Market, by Route of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Oral
10. Cholera Vaccines Market, by Dosage Form
10.1. Introduction
10.2. Liquid
10.3. Lyophilized
11. Cholera Vaccines Market, by Presentation Type
11.1. Introduction
11.2. Multi Dose
11.3. Single Dose
12. Cholera Vaccines Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Cholera Vaccines Market, by End User
13.1. Introduction
13.2. Ambulatory Centers
13.3. Clinics
13.4. Hospitals
13.5. Research Facilities
14. Cholera Vaccines Market, by Age Group
14.1. Introduction
14.2. Adult
14.3. Geriatric
14.4. Pediatric
15. Cholera Vaccines Market, by Application
15.1. Introduction
15.2. Prophylactic
15.3. Therapeutic
16. Americas Cholera Vaccines Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Cholera Vaccines Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Cholera Vaccines Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. EuBiologics Co., Ltd.
19.3.2. Shantha Biotechnics Private Limited
19.3.3. Incepta Vaccine Ltd.
19.3.4. Sanofi Pasteur S.A.
19.3.5. Valneva SE
19.3.6. Emergent BioSolutions Inc.
19.3.7. Bharat Biotech International Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CHOLERA VACCINES MARKET MULTI-CURRENCY
FIGURE 2. CHOLERA VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. CHOLERA VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CHOLERA VACCINES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CHOLERA VACCINES MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CHOLERA VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. CANADA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. CANADA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. GERMANY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 104. GERMANY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. FRANCE CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. FRANCE CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. FRANCE CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. ITALY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ITALY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. ITALY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. ITALY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. SPAIN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. SPAIN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. DENMARK CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. DENMARK CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. QATAR CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. QATAR CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. QATAR CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. QATAR CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. FINLAND CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. EGYPT CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. NORWAY CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. POLAND CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. POLAND CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 248. POLAND CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. POLAND CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. CHINA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 273. CHINA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 274. CHINA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. CHINA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. INDIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. INDIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 281. INDIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. INDIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. JAPAN CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. THAILAND CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. THAILAND CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY PRESENTATION TYPE, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM CHOLERA VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM CHOLERA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM CHOLERA VACCINES MARKET SIZE, BY D

Companies Mentioned

The companies profiled in this Cholera Vaccines market report include:
  • EuBiologics Co., Ltd.
  • Shantha Biotechnics Private Limited
  • Incepta Vaccine Ltd.
  • Sanofi Pasteur S.A.
  • Valneva SE
  • Emergent BioSolutions Inc.
  • Bharat Biotech International Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 329.81 Million
Forecasted Market Value ( USD ) by 2030 $ 470.18 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033 - Product Image

Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • 367 Pages
  • Global
From
Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cholera Vaccine Market

The Cholera Vaccine market is a subset of the larger Vaccines market. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. Vaccines are the most effective way to prevent cholera, and the World Health Organization recommends that all people at risk of cholera should be vaccinated. The Cholera Vaccine market is composed of a variety of products, including oral and injectable vaccines. Oral vaccines are typically administered in two doses, while injectable vaccines are administered in a single dose. The Cholera Vaccine market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Emergent BioSolutions. Each company offers a range of products, including both oral and injectable vaccines. Additionally, some companies have developed combination vaccines that protect against multiple diseases, including cholera. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.